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Abstract 
 
Extracellular vesicles (EVs) are small membrane-bound particles released by all cell 
types, including abundant release by platelets. EVs are a topic of increasing interest 
in the academic and clinical community due to their increasingly recognized and 
diverse role in normal biology as well as in disease. However, typical analysis 
methods to characterize EVs released by cell culture or isolated from whole blood or 
other body fluids are restricted to bulk analysis of all EVs in a sample. In this review 
we discuss the motivation for analysis of individual EVs, as well as discuss three 
emerging methods for physical and chemical characterization of individual EVs: 
Nanoparticle Tracking Analysis, Tunable Resistive Pulse Sensing, and Raman 
Spectroscopy. We give brief descriptions of the working principles of each technique, 
along with a review noting the benefits and limitations of each method as applied to 
detection of single EVs. 
 
1. Introduction & Motivation 
Extracellular vesicles (EVs) are sub–micron membrane-enclosed vesicles that are 
released from all cell types. EVs play key roles in many physiological and pathological 
processes and are an important mode of intercellular communication through the 
transfer of nucleic acids (principally RNA species) and proteins. The protein and RNA 
content of EVs is dependent on the cellular origin and the physiological and 
pathological processes of the parent cell. Consequently, EVs have great potential as 
biomarkers of disease and as novel targets for therapeutic intervention1. 
The measurement and characterisation of EVs presents unique problems. Most EV are 
50 to 200 nm in diameter and have a low refractive index, i.e., they scatter very little 
light2,3. This presents problems for detection by light scattering methods and the 
majority of EVs are undetectable by conventional flow cytometry. EVs are often 
polydisperse in size, ranging from 50 nm to over 1000 nm in diameter. Interference 
from lipoproteins4 and protein aggregates5 of similar size adds to the complexity. The 
scarcity and unpredictable expression of antigens makes labelling difficult. Antigen 
density on EVs is frequently low and expression of an antigen on the parent cell is no 
guarantee that the same antigen will be present on EVs released from that cell6.  
Furthermore, “typical” EV antigens (e.g., CD63) are not present on all EVs.  
Platelet-derived EVs (PEVs) were first described by Wolf7 as “platelet dust” with 
procoagulant activity in platelet poor plasma. Platelets release two types of vesicles: 
microvesicles (MV) (also referred to as microparticles or ectosomes)  which are 100 
nm to 1000 nm in diameter and bud directly from the plasma membrane; and 
exosomes which are typically smaller (generally considered to be 50 nm – 150 nm, 
but may be larger) and are released via multivesicular bodies8. It has been widely 
reported, and has been generally accepted, that PEVs are the most abundant type of 
circulating EV in the bloodstream, with estimates of 70-90% widely reported6,9,10. It 
was also thought that PEVs predominantly exposed phosphatidylserine (PS), and 
annexin V labelling was frequently used to identify EVs by flow cytometry11. This is 
because the origin of PEV was assumed to be activated platelets, as isolated platelets 
released a large number of PEVs when activated.  
 
However, it has been demonstrated that substantial amounts of PEVs (and non-PEVs 
as well) are generated in vitro artifactually in the blood collection tube, and acid-
citrate dextrose (ACD-A) tubes proved to be the most efficient in preventing this in 
vitro vesiculation12. Furthermore, recent studies using cryo-electron microscopy13 
and high sensitivity flow cytometry14 have shown that PEV may account for only 20 
to 30% of total EVs in normal plasma. It is notable that in these studies, many EVs 
isolated from plasma have no detectable cell-specific antigen at all. These ‘orphan’ 
EVs are predominantly <200 nm in diameter15 and it is highly probable that cell-
specific antigens are present but at a level below the limit of detection of flow 
cytometry. However, it is wrong to assume that, because the majority of large EVs are 
platelet derived, these orphan EVs have the same origin. Conversely, our inability to 
detect platelet markers on the smallest plasma EVs should not be taken as proof of 
absence. It is clear that improved labelling techniques are required to identify the 
cellular origin of the small unlabelled EVs. Lipoproteins (such as low density 
lipoprotein (LDL) particles) have been shown recently to mimic circulating EVs, and 
also to attach to the surface of EVs (possibly hindering EV markers)4. 
 
It is now known that the majority of PEVs isolated from normal plasma do not bind 
annexin V13,14,16. This is in contrast to PEVs shed by ionophore treated platelets, the 
majority of which expose sufficient PS to bind annexin V14. Furthermore, in healthy 
individuals, most circulating CD41 positive do not express platelet activation 
markers, e.g., CD63 and CD62P. These CD41+/CD62P- EVs lack LAMP-1 (lysosome-
associated membrane glycoprotein-1) but express full length filamin A, and are 
derived directly from megakaryocytes. In contrast, CD41+/CD62P+ EVs are LAMP-1 
positive and do not express full length filamin A17. This may explain the difference 
between the proteome of plasma -derived EVs and EVs shed by activated platelets18.  
 
It has long been known that PEVs have an important role in both normal haemostasis 
and thrombus formation. PEVs also play a key role in inflammation, atherosclerosis, 
neurodegenerative disorders, cancer progression and metastasis, angiogenesis and 
wound healing19. PEVs are a rich source of circulating miRNA20 and can deliver 
miRNA to endothelial cells21, macrophages22 and tumour cells23 resulting in altered 
gene expression. Consequently the study of PEVs and their effect on target cells will 
provide information on their important role as biomarkers or potential therapeutic 
agents. 
 
However, given the wide apparent variability in the physical properties (size, surface 
charge, refractive index) and chemical properties (surface marker expression, 
intravesicle cargo, etc.), bulk analyses of “PEVs” are not sufficient to characterize 
vesicle populations. For that reason, increasing emphasis has been placed on 
developing instrumentation and measurement methodologies allowing researchers 
to characterize these chemical and physical properties on vesicle by vesicle basis. In 
this review we describe the physical mechanisms underlying these emerging 
methods along with representative results. 
 
2. Nanoparticle Tracking Analysis 
Nanoparticle tracking analysis (NTA) is a method for visualising and characterising 
particles suspended in a liquid. During analysis, particles in suspension are 
illuminated by a focused laser beam and light is scattered in all directions by the 
particles. Although particles smaller than 200 nm in diameter are below the limit of 
resolution of light microscopy, scattered light collected at 90 degrees relative to the 
laser is focussed onto an image sensor of a camera, allowing the visualisation of the 
position of the particles in suspension. A useful analogy is that dust particles, too 
small to be seen with the naked eye, can be “seen” when they scatter sunlight. 
Nanoparticles suspended in a liquid move in Brownian motion at a rate determined 
by the viscosity of the liquid, the temperature of the liquid and the size of the particle, 
as shown schematically in Figure 1. Thus, if the “speed” (or mean square 
displacement) of a particle’s Brownian motion (the diffusion coefficient) and the 
viscosity and temperature of the liquid are known, the hydrodynamic radius of the 
particle may be calculated using the Stokes-Einstein equation.  
𝐷𝑡 =  
𝐾𝐵𝑇
3𝜋𝜂𝑑ℎ
   
Dt = diffusion coefficient, KB = Boltzman constant,  = viscosity,  
 T = absolute temperature, dh = hydrodynamic diameter 
A video recording of particles is made (acquisition) and the video is then analysed by 
the NTA software. NTA identifies and tracks each individual nanoparticle from frame 
to frame, hence the mean square displacement can be measured, and from it the 
diffusion coefficient is calculated24. Furthermore, the intensity of light scattered by 
the particles may be calculated, and from this a refractive index of each vesicle may 
be determined3,25. 
NTA is a useful method for the rapid (hundreds of EVs per minute) assessment of EV 
size, refractive index, and approximate concentration, as shown in Figure 2. It is most 
applicable to small EVs in the 50 nm – 250 nm range which are below the detection 
limit of conventional flow cytometry26. Measurements are typically made in isotonic 
phosphate buffered saline (PBS) which preserves the size of EVs and, as PBS has the 
same viscosity as distilled water (the default diluent for NTA), eliminates the 
necessity for measurement of viscosity.  
In order to measure EVs by NTA, the sample is diluted to approximately 1 – 10 x 
108/mL. It is preferable to make several short recordings (e.g. 10-30 recordings of 10-
30 seconds each), refreshing the sample between measurements to reduce sampling 
error and avoiding loss of EVs due to settling or adhesion27. The best camera level 
depends upon the size of the EVs. Ideally, each EV should be appear as a single point 
of light but this may be difficult to achieve if the EVs are highly polydisperse. For 
standard NanoSight systems (Malvern Instruments, UK) in earlier versions of NTA 
software, camera gain and shutter speed could be set using the advanced mode. In 
later versions, sixteen optimised camera levels are used ranging from level 1 (the least 
sensitive; gain 0, shutter speed 1) to level 16 (the most sensitive; gain 512, shutter 
speed 1,300). The NTA software settings are: detection threshold, minimum expected 
particle size, blur, minimum track length, and background subtraction. In recent 
versions of NTA software, these settings are automated with the exception of 
detection threshold. 
It is advisable to regularly check the performance of the instrument using 
microspheres of known size and concentration. In the past, most standardisation was 
performed using NIST-traceable polystyrene microspheres. However, polystyrene has 
a much higher refractive index (1.59) than EVs (Approximately 1.37 – 1.42), so silica 
microspheres (refractive index 1.47) are a more appropriate material for 
standardising EV measurements3,25. 
While the measurement of EV size and concentration can provide useful information, 
the ability to phenotype EVs using fluorescent labelling techniques is far more 
informative. Until now, single EV analysis using conventional antibody labelling has 
been largely restricted to the largest EVs of >300nm in diameter (approximately 1%). 
Most EV are 50 - 200 nm in diameter and antigen expression is typically low. While 
some next-generation flow cytometers can detect EVs as small as 120 nm, detection 
of specific antigens on small EVs has only been possible for a few highly expressed 
antigens. There are several reasons for this: the large size of IgG-fluorophore 
conjugates (20 -60 nm)28relative to EVs limits the number of molecules that can bind 
to a given EV; steric hindrance of IgG-antigen binding and antigen clustering further 
limit antigen detection; lastly, fluorophore conjugation is frequently unpredictable as 
the positioning of large fluorophores and the conjugation process itself may interfere 
with the antigen binding site. However, EVs generated from cells stably transfected 
with enhanced green fluorescent protein (EGFP) constructs are easily detectable 
using fluorescence NTA with a 488 nm laser source and a 500 nm long pass filter. 
Photon correlation spectroscopy showed that EVs expressing as few as 10 GFP 
molecules could be reliably detected by NTA (unpublished data). EGFP expressing 
EVs do not suffer from the background fluorescence associated with 
immunofluorescent or membrane labelling, so this level of sensitivity may not be 
achievable using these techniques. The problem lies not with the detection sensitivity 
of NTA but with the limitations of the labelling techniques. Direct26 and two stage 
labelling with quantum dots29 has been demonstrated but loss of antibody reactivity 
during conjugation, non-specific binding, quantum dot aggregation and background 
fluorescence have limited the successful application of this technique. 
Monoclonal antibodies optimised for flow cytometry are a 20th century solution to a 
21st century problem. There is a pressing need for extremely small, specific, high 
affinity fluorescently conjugated molecular probes for EV labelling. Fluorescently 
labelled aptamers, affibodies or nanobodies all offer potential solutions to specific EV 
labelling.  
3. Resistive Pulse Sensing 
Resistive pulse sensing, also known as the Coulter effect, describes the change in 
resistance between two electrodes as non-conducting particles pass through an 
aperture separating the electrodes, shown schematically in Figure 1. The electrodes 
are submerged in an electrolyte solution permitting a current to flow between them 
with a current drop across the electrodes due to the native resistance of the 
electrolyte solution. As particles pass through the aperture that separates the 
electrodes, they displace a certain volume of the electrolyte solution, changing the 
resistance of the circuit and causing an increasing drop in current, producing a 
“resistive pulse.” The size of this pulse is linearly proportional to the volume of the 
particle passing through the aperture. Resistive pulse sensing is widely used in 
hematology for sizing blood cells and platelets in standard hematology analyzers. 
However, the smallest volume that can be accurately recorded with these devices 
depends on the aperture size and detection electronics. Standard hematology 
analyzers, for example, have only in recent years been able to reliably report platelet 
volumes.  
A novel technology known as Tunable Resistive Pulse Sensing (TRPS) has recently 
been developed30 that permits accurate sizing and counting of very small particles 
with high accuracy by using a sub-micrometer pore poked in an elastic membrane. 
Due to the flexibility of the membrane, the pore itself can be dynamically adjusted, 
changing its size and conductive properties to best suit varying samples, or even to 
discriminate between different populations within a single experiment31. This 
technology provides a wealth of information about the particles passing through the 
aperture. By precisely controlling the flow-rate of particles through the system, as 
well as by varying the flow and charge in the device and using calibration particles, 
one can determine particle size, particle count (or concentration), as well as charge 
characteristics (Zeta potential/electrophoretic mobility), as shown in Figure 2. 
Commercial TRPS systems generally have a size detection threshold of around 40 nm, 
and an upper limit given by the pore size.  
TRPS is a relatively new technology, and as such the majority of published studies are 
currently examining the proper techniques and protocols for quantifying EVs using 
TRPS. Several studies have been made comparing several methods to determine the 
applicability of TRPS to EVs, concluding that, broadly speaking, under proper 
conditions, TRPS provides similar quantification ability compared to NTA and flow 
cytometery2,32-35. There is a single study examining the use of TRPS on quantifying 
platelet EVs, where their larger size compared with, for example, exosomes, makes 
them ideal targets for TRPS36. The relative simplicity and accuracy of TRPS 
measurements has helped it to rapidly transition to an accepted modality for 
characterization of EVs. For example, it was recently used as the standard method to 
evaluate different isolation procedures on exosome yield and size,37  and has been 
highlighted as an accepted characterization method in a ISEV position paper dating 
to 201238. Nevertheless, as with all techniques, TRPS has its own limitations that have 
been called out by several studies, such as minimum detectable size32 and maximum 
throughput35 that should be kept in mind. At higher throughputs (or with particles 
larger than the pore diameter), pore clogging can occur at unacceptable rates. 
Clogging requires the experiment to be paused to unclog the system, and the clog 
itself may alter the dimensions of the pore in unpredictable ways.34 Furthermore, 
while it characterizes physical parameters of EVs extremely well, it provides no 
information about chemical content, and there is no labelling technique to provide 
subpopulation specificity in TRPS measurements.   
However, recently it has been shown that TRPS can be efficiently combined with 
differential detergent lysis39. The disappearance of a TRPS signal at a given 
concentration of a detergent not only proves the vesicular nature of a particle, but it 
is also characteristic for size-based EV subpopulations. EVs with small diameter 
(~100 nm) are more resistant to detergent lysis than those with larger diameter 
(>150 nm) suggesting distinct membrane lipid composition (and possibly different 
biogenesis) of these EVs40. 
 
4. Raman Spectroscopy 
4a. Spontaneous Raman Scattering 
Raman scattering is the inelastic scattering of light by individual molecules. When a 
light source is incident on a molecule, there is a (small) chance of inelastic scattering 
of the photon, where energy is transferred either to or from the molecule, giving rise 
to scattered photons with wavelengths shifted from the incident source. The 
wavelength shifts for a given molecule depend on the molecule’s specific molecular 
arrangement, as shown in Figure 1. Thus, measuring the spectrum of these inelastic-
scattered photons, we obtain a “spectral fingerprint” for that molecule. Raman 
scattering can independently report on the chemical content of a wide variety of 
biomolecules in a single measurement with no need for any sample preparation or 
additional contrast agents. Due to these advantages, Raman spectroscopy is 
increasingly being explored as a fundamental analytical tool in biology and 
medicine41.  
In Raman spectroscopy, the sample volume probed by the system is determined by 
the area illuminated with the laser beam, which can be less than 1fL for tightly 
focused beams. This tightly focused laser can also trap and confine micro- and nano-
particles and keep them at the focus of the laser beam for prolonged measurements. 
This combination of optical trapping and Raman spectroscopy is termed Laser-
Tweezers Raman Spectroscopy (LTRS), and, since its introduction in the early 2000s, 
has been used in a wide range of single-cell and single-particle studies42-45.   
The ability to trap and observe chemical information from individual particles makes 
it particularly attractive for studies of chemical heterogeneity of EVs. Yet, possibly 
due to the difficulty in obtaining Raman spectra from EVs, relatively few such studies 
exist in the literature. Early results focus on measuring bulk preparations of EVs46. 
Following this, Tatischeff et al. used LTRS to trap and record Raman spectra of small 
numbers of EVs (approximately 2-10) released by Dictyostelium discoideum, as well 
from human urine samples47. The authors observed consistent changes in the 
composition of the EVs depending on the growth state of the Dictyostelium organism. 
Furthermore, they also observed that EVs from human urine appear to vary slightly 
based on donor, potentially indicating something about the patient health status.  
In 2015, Smith et al., recorded Raman spectra hypothesized to be from individual EVs 
extracted from a wide range of mammalian cell lines48.EVs from multiple cell lines 
grouped into four clusters with distinct biochemical composition. By analyzing the 
spectral features corresponding to each group, chemical differences were found to 
originate from membrane composition (cholesterol, lipid:cholesterol ratio, and 
surface protein expression).   These results not only demonstrate the level of chemical 
detail afforded by Raman spectroscopy, but also highlighting the heterogeneity of 
vesicle composition even from the highly idealized samples of immortalized cell lines. 
This further underscores the importance of single-vesicle methods described in this 
review. Representative results of Raman spectra of vesicle samples are shown in 
Figure 2. 
Despite Raman spectroscopy’s unique advantages, it suffers from extremely long 
integration times (ranging from 1 to 5 minutes per vesicle), that limits its ability to be 
used in a clinical setting (as contrasted with basic biological studies). This places the 
throughput of spontaneous-Raman-based systems 4-5 orders of magnitude lower 
than methods such as NTA or TRPS. To overcome this drawback, some researchers 
have been exploring methods to increase the signal strength and overall throughput 
of Raman measurements of EVs, as described below. 
4b: Surface Enhanced Raman Scattering (SERS) 
After the discovery of great enhancement of Raman scattering of pyridine molecules 
adsorbed on the surface of roughened silver in 197349, Surface Enhanced Raman 
Spectroscopy (SERS) has been widely applied for the detection and analysis of 
biological samples including molecules, proteins and cells50,51. When light of an 
appropriate frequency interacts with the metallic structure, a surface plasmon (a 
collective oscillation of the electrons) forms and propagates on the surface of the 
metal. This gives rise to an enhanced electromagnetic field near the nanostructure 
depending on the structure of the nanomaterials. This enhanced electromagnetic field 
greatly intensifies the generated Raman scattering, with enhancement factors as 
ranging from 106 to 1015 reported. Since it is a surface plasmon which excites the 
molecules for the SERS process, the sample of interest should be located within 5 nm 
from the surface of the metallic nanostructured substrate. 
The SERS technique was applied for the rapid biochemical analysis of the vesicle 
surface contents including membranes and surface proteins. Kerr et al. reported 
SERS analysis on ovarian tumor derived EVs by mixing the EVs with gold 
nanoparticles52, while Tirinato et al. showed SERS spectra purportedly arising from 
EVs on super-hydrophobic nanopillars53. However, because the authors did not 
correct for the SERS signal of the isolation kit used in the study, a substantial portion 
of that signal is likely to be from that contaminant48,54, highlighting some of the 
difficulty in performing label-free measurements on chemically complex samples 
such as EVs. Lee et al., developed an efficient substrate system to capture and SERS-
analyze EVs using nanobowl shaped planar, thin-metal coated substrates54. In this 
work, the authors have shown a simple, soft lithographic method for the substrate 
fabrication using flexible poly(dimethylsiloxane) (PDMS) templates on which a thin 
layer of silver is sputtered. The sputtered surface has a significantly lower 
background compared with SERS particles prepared via reduction methods. Results 
also suggest that the bowl-shaped substrate allows intact and ruptured EVs to be 
measured using time-dependent measurements, where spectra were measured at 
different time points as the sample solution dried on the substrate showed peak 
evolution over the extended time period.  
Stremersch et al. describe coating individual exosome-like vesicles (ELVs) with 10nm 
gold nanoparticles coated with 4-dimethylaminopyridine (DMAP)55. This coating 
gave the nanoparticles a strong surface charge that allowed electrostatic binding to 
the ELVs. After depositing a prepared sample on a quartz surface, the authors were 
able to record SERS signals from what are hypothesized to be individual ELVs, 
showing distinct spectral differences from ELVs obtained from two separate cell 
types. However, the strong background from the DMAP itself makes interpretation of 
the spectra difficult, highlighting an additional challenge of  SERS measurements, 
where subtle changes in the nanostructure used to enhance the signal has a very 
strong impact on the recorded spectrum. 
5. Future Outlook & Concluding Remarks 
Here we have presented several techniques capable of single-exosome analysis. 
Some, like Raman spectroscopy, remain largely unexplored, while others, such as 
NTA, have become standard methods in exosome analysis. However, even for 
standard techniques such as NTA, significant unanswered questions remain 
regarding preparation protocols and analysis methods. Furthermore, the increasing 
availability of optical labels such as fluorophores or highly Raman-active compounds 
that are conjugated to molecularly specific small molecules such as peptides, 
aptamers, etc., have the potential to continue to revolutionize the ease, specificity, and 
applicability of these methods to vesicle analysis.  
The pressing need for single-vesicle analysis methods will also undoubtedly lead to 
the development of additional techniques not described here. For example, surface 
plasmon resonance (SPR) have recently been used to do detailed molecular profiling 
of extracellular vesicles56,57. While plasmon-based techniques currently are 
performed only on bulk samples, similar platforms have already been shown to have 
achieved sensitivity to single-molecule binding events58. Therefore, it is not difficult 
to envision single-exosome studies using these methods arriving in the near future. 
Another promising method is a recently-developed microtoroid-based biosensor59. 
In this technology, nicknamed FLOWER (Frequency Locked Optical Whispering 
Evanescent Resonator) a tunable laser probes the resonant frequency of a single silica 
microtoroid coated with capture antibodies. As a sample is washed over the toroid, 
EVs with the appropriate surface markers bind to the toroid and with each binding 
event the resonant frequency shifts slightly. Thus FLOWER, similarly to NTA or TRPS 
is able to provide an accurate count of vesicle subpopulations, in addition to other 
physical parameters such as size and dry mass based on the magnitude of the change 
in resonant frequency upon binding.  
The study of extracellular vesicles is still a nascent one, and thus researchers are 
forced to grapple simultaneously with critical biological questions and critical 
technological or practical questions arising due to the lack of standard techniques and 
protocols with long and established histories. Thus technologists and clinical or 
biological researchers alike must continue to work together to pave the way forward 
to precise, accurate, and repeatable characterization of these highly challenging and 
heterogeneous samples. 
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Tables and Figures 
Table 1: A basic description of three methods for quantification of single vesicle characterization 
methods. 
 
 
  
Method 
Physical 
Mechanism 
Supplied 
Information 
Throughput 
ISEV 
Standard 
NTA 
Light scattering, 
fluorescence 
Number, size, 
refractive index, 
surface marker 
6000/min Yes 
TRPS Coulter effect Number, size, charge 3000/min Yes 
Raman 
Inelastic light 
scattering 
Number, Chemical 
makeup 
~0.2/min 
(spontaneous) 
No 
Figure 1: Schematic diagram of single-vesicle measurement methods. As described in detail in the 
text, vesicles of assorted size, internal contents, and membrane composition, are measured by 
imaging, voltage pulses, and optical spectroscopy. 
  
 
 
 
 
Figure 2: Representative data obtained by NTA, TRPS, and Raman methods. NTA provides (a) 
concentration versus size and (b) refractive index and size of individual EVs. TRPS provides (c) 
concentration versus size and (d) size and ζ-potential of individual EVs. Raman provides (e) overall 
chemical content of the vesicle and (f) distributions of individual chemicals for individual EVs. (a) 
and (e) are adapted from Ref. 47 under the terms of a CC BY-NC license, (b) is adapted from Ref. 3 
under the terms of a CC BY-NC license. (c) is adapted from Ref. 34 under the terms of a CC BY-NC 
license. (d) is adapted with permission from Ref. 60, Copyright 2012 American Chemical Society. (f) is 
adapted from Ref. 48 under the terms of a CC BY-NC license.  
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